TNYA

0.9469

6.25% -0.0631

Dopo l'orario di chiusura: .70 -0.2469 -26.07%

Tenaya Therapeutics Inc (TNYA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.01

Aprire:

$1.02

Volume 24 ore:

1.31M

Relative Volume:

0.35

Capitalizzazione di mercato:

$78.59M

Reddito:

Utile/perdita netta:

$-117.23M

Rapporto P/E:

-0.6576

EPS:

-1.44

Flusso di cassa netto:

$-95.25M

1 W Prestazione:

-12.32%

1M Prestazione:

-9.82%

6M Prestazione:

-62.57%

1 anno Prestazione:

-85.80%

Intervallo 1D:

$0.94

$1.025

Intervallo di 1 settimana:

$0.94

$1.09

Portata 52W:

$0.8606

$7.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Nome

Tenaya Therapeutics Inc

Settore

Healthcare (1189)

Industria

Biotechnology (682)

Telefono

415-865-2066

Indirizzo

171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO

Dipendente

140

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

TNYA's Discussions on Twitter

Confronta TNYA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TNYA Tenaya Therapeutics Inc	0.9469	78.59M	0	-117.23M	-95.25M	-1.44
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-10	Iniziato	William Blair	Outperform
2023-11-30	Iniziato	Leerink Partners	Outperform
2022-06-15	Iniziato	H.C. Wainwright	Buy

Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie

04:25 AM

Tenaya Therapeutics announces securities offering - Investing.com India

04:25 AM

04:11 AM

Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire

04:11 AM

04:10 AM

Heart Disease Biotech Tenaya Seeks Fresh Capital Through Complex Warrant Offering - StockTitan

04:10 AM

08:27 AM

Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - The Manila Times

08:27 AM

08:00 AM

Can Tenaya's Heart Disease Therapies Impress Investors at March Conferences? - StockTitan

08:00 AM

Feb 27, 2025

H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock - MSN

Feb 27, 2025

Feb 26, 2025

Monitoring Tenaya Therapeutics Inc (TNYA) after recent insider movements - Knox Daily

Feb 26, 2025

Feb 22, 2025

Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World

Feb 22, 2025

Feb 20, 2025

Taking on analysts’ expectations and winning: Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 20, 2025

Feb 14, 2025

SG Americas Securities LLC Purchases 15,777 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Feb 14, 2025

Feb 12, 2025

It is Poised to be a Bull Market for Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 12, 2025

Feb 11, 2025

Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News

Feb 11, 2025

Feb 10, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Feb 10, 2025

Tenaya Therapeutics appoints new interim principal accounting officer - MSN

Feb 10, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $17.33 - Defense World

Feb 10, 2025

Feb 07, 2025

Tenaya Therapeutics appoints new interim principal accounting officer By Investing.com - Investing.com Canada

Feb 07, 2025

Tenaya Therapeutics Appoints Interim Accounting Officer - TipRanks

Feb 07, 2025